Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.85 USD | +2.99% | -3.15% | +66.73% |
04:07pm | Merus Says US FDA Grants Breakthrough Therapy Designation for Petosemtamab | MT |
02:54pm | Merus Carcinoma Treatment Awarded US FDA's Breakthrough Therapy Designation | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+66.73% | 2.61B | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- MRUS Stock
- News Merus N.V.
- Needham Adjusts Price Target on Merus to $46 From $33, Keeps Buy Rating